NABL Certified Labs

Book Potassium Test

35+ Regional Processing Labs
4500+ Serviceable Pincodes across India
75000+ Samples Processed Daily

Test Price

₹245

Book Now
Free Home Collection Reports In 24 - 48 Hours

Quick Potassium Test Overview

Also Known As Serum Potassium, K Test, Electrolyte Potassium
Sample Type Blood (Serum)
Fasting Required Yes, 8 hours
Report Delivery Within 24 hours
Age Group Adults
Gender All
Test Type Ion-Selective Electrode Assay
Units mEq/L or mmol/L
1

The Potassium test is a blood test that measures the concentration of potassium, the most abundant intracellular cation in the human body, in the blood serum. Approximately 98 percent of the body's total potassium is stored within cells, particularly in muscle, liver, and red blood cells, with only two percent circulating in the extracellular fluid and bloodstream. This narrow extracellular concentration is maintained within a very tight physiological range through the coordinated actions of the sodium-potassium ATPase pump, renal tubular regulation under the influence of aldosterone, acid-base status, and insulin, because even small deviations from the normal range have profound consequences for cardiac electrical conduction, neuromuscular function, and cellular metabolism. Potassium plays an indispensable role in maintaining the resting membrane potential of excitable cells including cardiac myocytes, skeletal muscle fibres, and neurons. The ratio of intracellular to extracellular potassium concentration determines cellular excitability, and disruptions to this ratio cause the characteristic clinical manifestations of potassium disorders. Hypokalaemia, or low serum potassium, increases cellular excitability and predisposes to cardiac arrhythmias, muscle weakness, and paralytic ileus, while hyperkalaemia, or high serum potassium, decreases excitability and causes potentially fatal cardiac conduction abnormalities including ventricular fibrillation and asystole. In India, potassium disorders are encountered across virtually every clinical specialty. Hypokalaemia is particularly prevalent in patients with chronic diarrhoeal illness, malnutrition, diuretic use, and hyperaldosteronism, while hyperkalaemia is a common and potentially life-threatening complication of chronic kidney disease, diabetic nephropathy, and the widespread use of renin-angiotensin-aldosterone system blocking medications. The test is performed on a small blood sample drawn from a vein and completed in under five minutes.
2

Doctors prescribe a Potassium test in the following situations: Investigating cardiac arrhythmias where both hypokalaemia and hyperkalaemia are well-established and potentially fatal causes of abnormal cardiac rhythm including ventricular tachycardia, torsades de pointes, and life-threatening conduction blocks, and where urgent potassium measurement is essential before and during antiarrhythmic therapy. Monitoring patients on diuretic therapy where loop diuretics including furosemide and thiazide diuretics cause significant renal potassium wasting, and serial potassium measurements guide supplementation decisions to maintain levels within the safe therapeutic range and prevent diuretic-induced hypokalaemia-related arrhythmias. Evaluating chronic kidney disease in patients with progressive renal impairment where diminished renal potassium excretion capacity leads to hyperkalaemia, a potentially fatal complication that requires close monitoring, dietary potassium restriction, and medical management with potassium binders or dialysis as renal function deteriorates. Assessing patients with vomiting, diarrhoea, and gastrointestinal losses where significant potassium depletion from gastrointestinal secretions causes hypokalaemia requiring quantification and correction to prevent cardiac and neuromuscular complications, particularly in children with acute gastroenteritis and elderly patients with poor oral intake. Investigating primary hyperaldosteronism in patients with difficult to control hypertension and spontaneous hypokalaemia where excess aldosterone drives renal potassium wasting, and potassium measurement alongside plasma aldosterone to renin ratio forms the initial screening investigation for this surgically correctable cause of secondary hypertension. Monitoring patients on medications that significantly alter potassium levels including ACE inhibitors, angiotensin receptor blockers, potassium-sparing diuretics, digoxin, insulin, and beta-adrenergic agents where regular potassium surveillance prevents clinically significant electrolyte disturbances from developing undetected during long-term treatment.
3

The Potassium test measures the concentration of potassium ions in the blood serum, expressed in milliequivalents per litre (mEq/L) or millimoles per litre (mmol/L). The normal reference range for adults is 3.5 to 5.0 mEq/L, with no clinically significant variation by gender and only minor age-related changes. Normal (3.5 to 5.0 mEq/L) A result within the normal range indicates that serum potassium is within the safe physiological range for normal cardiac and neuromuscular function. In patients on medications that affect potassium levels, a normal result confirms that current dosing and dietary management are maintaining adequate electrolyte balance without clinically significant deviation in either direction. Low Potassium or Hypokalaemia (Below 3.5 mEq/L) A serum potassium below 3.5 mEq/L confirms hypokalaemia, with severity classified as mild at 3.0 to 3.5 mEq/L, moderate at 2.5 to 3.0 mEq/L, and severe below 2.5 mEq/L. Mild hypokalaemia may be asymptomatic or cause fatigue and muscle cramps, while moderate to severe hypokalaemia causes progressive muscle weakness, paralysis, constipation, and life-threatening ventricular arrhythmias requiring prompt oral or intravenous potassium replacement under medical supervision. Elevated Potassium or Hyperkalaemia (Above 5.0 mEq/L) A serum potassium above 5.0 mEq/L confirms hyperkalaemia, with levels above 6.0 mEq/L constituting a medical emergency requiring immediate cardiac monitoring and treatment. Hyperkalaemia causes characteristic ECG changes progressing from tall peaked T waves to widened QRS complexes and ultimately to ventricular fibrillation and cardiac arrest if untreated. Immediate treatment includes calcium gluconate for cardiac membrane stabilisation, insulin-glucose infusion for cellular potassium uptake, and potassium elimination through diuretics, potassium binders, or emergency dialysis.
4

Fasting for 8 hours before the Potassium test is recommended, particularly when ordered as part of a comprehensive metabolic panel alongside renal function, glucose, and other electrolytes, as this ensures standardised conditions for the entire panel and avoids the minor transient effects of recent food intake on electrolyte measurements. Water is permitted during the fasting period. Avoid prolonged fist clenching and tight tourniquet application during blood collection, as both practices cause localised muscle potassium release that can falsely elevate the result through a phenomenon known as pseudohyperkalaemia. Inform your phlebotomist that the test includes potassium measurement so that appropriate gentle technique is used to minimise in vitro haemolysis, which releases intracellular potassium from red blood cells and is the most common cause of a spuriously elevated potassium result. Inform your doctor about all medications currently being taken before the test, particularly diuretics, ACE inhibitors, ARBs, potassium supplements, potassium-sparing diuretics, NSAIDs, heparin, and digoxin, as these directly influence serum potassium levels and are essential context for accurate clinical interpretation. If you are undergoing serial potassium monitoring for chronic kidney disease or cardiac management, consistent timing, fasting conditions, and use of the same laboratory platform ensures reliable trend comparison across visits. Staying well hydrated before the blood draw facilitates easier venous access and minimises haemolysis risk during sample collection.
5

If you are booking through the SecondMedic platform the Potassium test price starts at approximately Rs. 245. The exact price will be confirmed at the time of booking through SecondMedic. If your doctor has prescribed multiple tests alongside Potassium, SecondMedic health packages include Potassium as part of a broader electrolyte and metabolic panel at a significantly lower combined price.
6

SecondMedic offers convenient home sample collection for the Potassium test across India, making it easy to get tested without visiting a diagnostic centre. Home collection is available free of charge for orders above Rs. 300. A trained phlebotomist will visit your preferred address between 7 AM and 10 PM, seven days a week, including Sundays and public holidays. Your blood sample is processed at NABL-accredited partner laboratories, and your report is delivered within 24 hours directly to your WhatsApp and email.

Our Presence In India

People Also Ask

As kidney function declines, the ability to excrete potassium diminishes progressively, leading to hyperkalaemia. Levels above 6.0 mEq/L are a cardiac emergency, so regular potassium monitoring is essential to guide dietary restriction, potassium binder therapy, and dialysis decisions in CKD patients.

ACE inhibitors, angiotensin receptor blockers, potassium-sparing diuretics such as spironolactone, NSAIDs, and heparin are the most frequent drug-related causes of clinically significant hyperkalaemia. Patients on these medications, particularly those with CKD or diabetes, require regular potassium surveillance.

Content Reviewed By

Reviewer
Reviewed by:

Dr. Kovid Pandey

MBBS, General Physician

Last Reviewed: 10th Mar 2026

References

1
Hyperkalaemia Clinical Practice Guideline Working Group: Management of Hyperkalaemia in Patients with Kidney Disease, Kidney International Supplements, 2020 — doi.org
2
Kardalas E et al.: Hypokalaemia: A Clinical Update, Endocrine Connections, 2018 — doi.org
3
National Kidney Foundation: Potassium and Your CKD Diet, NKF Patient Education Resources, 2023 — www.kidney.org
4
Funder JW et al.: The Management of Primary Aldosteronism, Journal of Clinical Endocrinology and Metabolism, 2016 — doi.org
5
Weir MR and Rolfe M: Potassium Homeostasis and Renin-Angiotensin-Aldosterone System Inhibition, Clinical Journal of the American Society of Nephrology, 2010 — doi.org

Download Our App & Get Consultation from anywhere.

App Download